AstraZeneca CEO UK’s highest paid company boss in 2020

Published On: August 19, 2021Categories: Latest News1.3 min read

According to a report from the High Pay Centre, Soriot took home $21.25 million last year

Pascal Soriot, the chief executive of COVID-19 vaccine maker AstraZeneca, was the UK’s highest paid company boss in 2020, a year when the average FTSE 100 leader saw their pay drop by nearly a fifth, a report on Thursday showed.

According to a report from the High Pay Centre, Soriot took home 15.45 million pounds ($21.25 million). Soriot’s handling of the pandemic response has drawn criticism despite the company producing its vaccine at cost price.

That compares with median pay for CEOs in the UK’s flagship stock index of 2.69 million pounds, down from 3.25 million pounds in 2019, the report found, but still 86 times the median earnings for the average UK worker.

Shareholders had demanded bosses share the financial pain as companies across a range of sectors experienced a tough year, with lockdowns in many countries hitting sales.

The proportion of companies paying bonuses declined to 64% from 89% in 2019, while 77% paid out long-term incentives based on performance over the previous 3-5 years, compared to 82% the previous year.

Of the nine companies which took public money through the British government’s furlough scheme, the average CEO pay was 2.2 million pounds.

CEO pay packages are designed to reflect the experience of shareholders, employees and other stakeholders so in one sense the lower pay levels this year show the system working as intended, said High Pay Centre Director Luke Hildyard.

He said: On the other hand, these are still very generous rewards at a time when, in general, government support for the economy has probably been more important to the survival and success of the UK’s biggest companies than the decisions of their executives.

About the Author: Jonathan Adams

Latest articles

Corporate bonds are back in favour as Meta launches $10 billion offering to following Apple and Intel: would your portfolio benefit from a fixed income allocation?

August 8, 2022|

Go to Top